67 related articles for article (PubMed ID: 4019647)
1. Simultaneous high-performance liquid chromatographic assay for 5-(2-bromo-E-ethenyl)-2'-deoxyuridine and its metabolite, 5-(2-bromo-E-ethenyl)uracil, in plasma.
Robinson Y; Gerry N; Vose CW
J Chromatogr; 1985 Feb; 338(1):219-24. PubMed ID: 4019647
[No Abstract] [Full Text] [Related]
2. High-performance liquid chromatographic method for the determination of bromodeoxyuridine and its major metabolite, bromouracil, in biological fluids.
Stetson PL; Shukla UA; Amin PR; Ensminger WD
J Chromatogr; 1985 May; 341(1):217-22. PubMed ID: 4019689
[No Abstract] [Full Text] [Related]
3. Improved high-performance liquid chromatographic assay for the quantification of 5-bromo-2'-deoxyuridine and 5-bromouracil in plasma.
Ganes DA; Wagner JG
J Chromatogr; 1988 Nov; 432():233-42. PubMed ID: 3220891
[TBL] [Abstract][Full Text] [Related]
4. Identification of a plasma metabolite of 5-(2-bromo-E-ethenyl)-2'-deoxyuridine.
Robinson Y; Gerry N; Brownsill RD; Vose CW
Biomed Mass Spectrom; 1984 Apr; 11(4):199-201. PubMed ID: 6733256
[TBL] [Abstract][Full Text] [Related]
5. Phosphorolysis of (E)-5-(2-bromovinyl)-2'-deoxyuridine (BVDU) and other 5-substituted-2'-deoxyuridines by purified human thymidine phosphorylase and intact blood platelets.
Desgranges C; Razaka G; Rabaud M; Bricaud H; Balzarini J; De Clercq E
Biochem Pharmacol; 1983 Dec; 32(23):3583-90. PubMed ID: 6651877
[TBL] [Abstract][Full Text] [Related]
6. Determination of (E)-5-(2-bromovinyl)-2'-deoxyuridine in plasma and urine by capillary electrophoresis.
Olgemöller J; Hempel G; Boos J; Blaschke G
J Chromatogr B Biomed Sci Appl; 1999 Apr; 726(1-2):261-8. PubMed ID: 10348194
[TBL] [Abstract][Full Text] [Related]
7. Deoxyribosyl exchange reactions leading to the in vivo generation and regeneration of the antiviral agents (E)-5-(2-bromovinyl)-2'-deoxyuridine, 5-ethyl-2'-deoxyuridine and 5-(2-chloroethyl)-2'-deoxyuridine.
Desgranges C; De Clercq E; Razaka G; Drouillet F; Belloc I; Bricaud H
Biochem Pharmacol; 1986 May; 35(10):1647-53. PubMed ID: 3011010
[TBL] [Abstract][Full Text] [Related]
8. The degradation of 5-iododeoxyuridine and 5-bromodeoxyuridine by serum from different sources and its consequences for the use of the compounds for incorporation into DNA.
Saffhill R; Hume WJ
Chem Biol Interact; 1986 Mar; 57(3):347-55. PubMed ID: 3698122
[TBL] [Abstract][Full Text] [Related]
9. Bioanalysis of (E)-5-(2-bromovinyl)-2'-deoxyuridine.
Reeuwijk HJ; Lingeman H; Tjaden UR; de Bruijn EA; Keizer HJ; van der Greef J
J Chromatogr; 1988 Jun; 428(1):93-102. PubMed ID: 3170680
[TBL] [Abstract][Full Text] [Related]
10. Manual and automated determination of 1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil and its metabolite (E)-5-(2-bromovinyl)uracil in urine.
Whigan DB; Schuster AE
J Chromatogr B Biomed Appl; 1995 Feb; 664(2):357-63. PubMed ID: 7780588
[TBL] [Abstract][Full Text] [Related]
11. Potent anti-viral 5-(2-bromovinyl) uracil nucleosides are inactive at inducing gene mutations in Salmonella typhimurium and V79 Chinese hamster cells and unscheduled DNA synthesis in primary rat hepatocytes.
Marquardt H; Westendorf J; De Clercq E; Marquardt H
Carcinogenesis; 1985 Aug; 6(8):1207-9. PubMed ID: 3893787
[TBL] [Abstract][Full Text] [Related]
12. Development and validation of a bioanalytical assay for (E)-5-(2-bromovinyl)-2'deoxyuridine in plasma by capillary zone electrophoresis.
Reeuwijk HJ; Tjaden UR; van der Greef J
J Chromatogr B Biomed Sci Appl; 1999 Apr; 726(1-2):269-76. PubMed ID: 10348195
[TBL] [Abstract][Full Text] [Related]
13. High-performance liquid chromatographic analysis of (E)-5-(2-bromovinyl)-2'-deoxyuridine and its metabolites in serum, urine and herpes simplex virus type-1 infected cells.
Ayisi NK; Wall RA; De Clercq E; Sacks SL
J Chromatogr; 1986 Mar; 375(2):423-30. PubMed ID: 3700568
[No Abstract] [Full Text] [Related]
14. Evaluation of antisera to 5-(2-bromo-E-ethenyl)-2'-deoxyuridine for the radioimmunoassay of a potent antiviral agent.
Jackson LS; Stafford JE
J Pharmacol Methods; 1989 Sep; 22(2):125-32. PubMed ID: 2811389
[TBL] [Abstract][Full Text] [Related]
15. High-performance liquid chromatographic determination of 1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil and its metabolite (E)-5-(2-bromovinyl)uracil in serum.
Whigan DB; Cohen AI
J Chromatogr; 1991 Aug; 568(2):385-92. PubMed ID: 1783644
[TBL] [Abstract][Full Text] [Related]
16. High-performance liquid chromatographic analysis of 5-ethylpyrimidines and 5-methylpyrimidines in plasma.
Joly JM; Williams WM
J Chromatogr; 1991 Feb; 563(2):392-9. PubMed ID: 1878072
[TBL] [Abstract][Full Text] [Related]
17. The effect of sorivudine on dihydropyrimidine dehydrogenase activity in patients with acute herpes zoster.
Yan J; Tyring SK; McCrary MM; Lee PC; Haworth S; Raymond R; Olsen SJ; Diasio RB
Clin Pharmacol Ther; 1997 May; 61(5):563-73. PubMed ID: 9164418
[TBL] [Abstract][Full Text] [Related]
18. Lack of susceptibility of bicyclic nucleoside analogs, highly potent inhibitors of varicella-zoster virus, to the catabolic action of thymidine phosphorylase and dihydropyrimidine dehydrogenase.
Balzarini J; Sienaert R; Liekens S; Van Kuilenburg A; Carangio A; Esnouf R; De Clercq E; McGuigan C
Mol Pharmacol; 2002 May; 61(5):1140-5. PubMed ID: 11961132
[TBL] [Abstract][Full Text] [Related]
19. Prediction of in vivo drug-drug interactions based on mechanism-based inhibition from in vitro data: inhibition of 5-fluorouracil metabolism by (E)-5-(2-Bromovinyl)uracil.
Kanamitsu SI; Ito K; Okuda H; Ogura K; Watabe T; Muro K; Sugiyama Y
Drug Metab Dispos; 2000 Apr; 28(4):467-74. PubMed ID: 10725316
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics and bioavailability of 5-ethyl-2'-deoxyuridine and its novel (5R,6R)-5-bromo-6-ethoxy-5,6-dihydro prodrugs in mice.
Cheraghali AM; Kumar R; Knaus EE; Wiebe LI
Drug Metab Dispos; 1995 Feb; 23(2):223-6. PubMed ID: 7736915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
